Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanocort vs Solu-Medrol in Acute MS Exacerbation
NCT01039103Phase 2Terminated
- Sponsor
- Galapagos NV
- Start
- Dec 2009
- Primary completion
- Nov 2011
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 2 trial of liposomal prednisolone in relapsing-remitting multiple sclerosis (RRMS), clinically isolated syndrome (CIS), sponsored by Galapagos NV. Started Dec 2009; status: terminated.
02
Drugs
liposomal prednisolone
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)clinically isolated syndrome (CIS)
Beyond the preview
Go deeper on NCT01039103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01039103.